Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (731)
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,102
Price
$359.12
Total Value
$5.06M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,899
Price
$358.41
Total Value
$7.49M
Shares Held After
14,102
% of Holdings
59.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,396
Price
$357.63
Total Value
$5.51M
Shares Held After
35,001
% of Holdings
30.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,515
Price
$356.43
Total Value
$896.43K
Shares Held After
50,397
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,980
Price
$354.71
Total Value
$702.32K
Shares Held After
52,912
% of Holdings
3.6%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
11,048
Price
$27.25
Total Value
$301.06K
Shares Held After
92,211
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,361,053
% of Holdings
0.4%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
619
Price
$25.00
Total Value
$15.47K
Shares Held After
35,072
% of Holdings
1.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Chaudhuri Sarbani — Chief Commercial&Medical Affairs Officer
Shares
4,701
Price
$3.50
Total Value
$16.45K
Shares Held After
262,809
% of Holdings
1.8%
Wave Life Sciences, Inc. (WVE)
Wagner Heidi L — Director
Shares
7,000
Price
$6.01
Total Value
$42.07K
Shares Held After
44,930
% of Holdings
13.5%
Wave Life Sciences, Inc. (WVE)
Tan Aik Na — Director
Shares
432
Price
$6.01
Total Value
$2.60K
Shares Held After
24,968
% of Holdings
1.7%
Wave Life Sciences, Inc. (WVE)
TAKANASHI KEN — Director
Shares
3,864
Price
$6.01
Total Value
$23.22K
Shares Held After
20,079
% of Holdings
16.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
2,666
Price
$360.00
Total Value
$959.76K
Shares Held After
0
% of Holdings
100.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
8,300
Price
$26.52
Total Value
$220.13K
Shares Held After
119,289
% of Holdings
6.5%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
25,000
Price
$44.00
Total Value
$1.10M
Shares Held After
174,209
% of Holdings
12.5%
Denali Therapeutics Inc. (DNLI)
Schuth Alexander O. — COFO and Secretary
Shares
2,857
Price
$25.07
Total Value
$71.62K
Shares Held After
281,763
% of Holdings
1.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
368
Price
$13.96
Total Value
$5.14K
Shares Held After
145,937
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
1,775
Price
$13.96
Total Value
$24.78K
Shares Held After
704,781
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Stevens Christopher James — Chief Operating Officer
Shares
36,658
Price
$3.50
Total Value
$128.27K
Shares Held After
505,784
% of Holdings
6.8%
Xenon Pharmaceuticals Inc. (XENE)
GANNON STEVEN — Director
Shares
10,000
Price
$64.06
Total Value
$640.55K
Shares Held After
1,870
% of Holdings
84.2%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
460,000
Price
$0.64
Total Value
$292.10K
Shares Held After
1,343,886
% of Holdings
34.2%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
20,206
Price
$9.95
Total Value
$201.15K
Shares Held After
62,161
% of Holdings
24.5%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
34,239
Price
$148.52
Total Value
$5.09M
Shares Held After
523,478
% of Holdings
6.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4
Price
$367.00
Total Value
$1.47K
Shares Held After
54,892
% of Holdings
0.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,200
Price
$366.31
Total Value
$439.57K
Shares Held After
54,896
% of Holdings
2.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,176
Price
$365.26
Total Value
$1.16M
Shares Held After
56,096
% of Holdings
5.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,211
Price
$364.31
Total Value
$1.90M
Shares Held After
59,272
% of Holdings
8.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,403
Price
$363.45
Total Value
$4.87M
Shares Held After
64,483
% of Holdings
17.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
11,568
Price
$362.34
Total Value
$4.19M
Shares Held After
77,886
% of Holdings
12.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,569
Price
$361.47
Total Value
$5.27M
Shares Held After
89,454
% of Holdings
14.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
8,081
Price
$360.33
Total Value
$2.91M
Shares Held After
104,023
% of Holdings
7.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,695
Price
$359.32
Total Value
$4.92M
Shares Held After
112,104
% of Holdings
10.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
62,291
Price
$26.23
Total Value
$1.63M
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
6,001
Price
$99.90
Total Value
$599.51K
Shares Held After
36,355
% of Holdings
14.2%
Avalo Therapeutics, Inc. (AVTX)
Riley Jennifer — Chief Strategy Officer
Shares
2,655
Price
$19.59
Total Value
$52.01K
Shares Held After
37,041
% of Holdings
6.7%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
2,600
Price
$9.63
Total Value
$25.04K
Shares Held After
77,900
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$531.01
Total Value
$148.68K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$529.05
Total Value
$75.65K
Shares Held After
324,723
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
737
Price
$528.07
Total Value
$389.19K
Shares Held After
324,866
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
935
Price
$527.16
Total Value
$492.90K
Shares Held After
325,603
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,725
Price
$526.05
Total Value
$1.43M
Shares Held After
326,538
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
871
Price
$525.19
Total Value
$457.44K
Shares Held After
329,263
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$524.13
Total Value
$198.65K
Shares Held After
330,134
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
221
Price
$523.04
Total Value
$115.59K
Shares Held After
330,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$521.73
Total Value
$104.35K
Shares Held After
330,734
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$520.59
Total Value
$104.12K
Shares Held After
330,934
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$518.95
Total Value
$62.27K
Shares Held After
331,134
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$517.57
Total Value
$62.11K
Shares Held After
331,254
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$516.91
Total Value
$268.79K
Shares Held After
331,374
% of Holdings
0.2%
Showing 101–150 of 731 transactions (page 3 of 15)